With our proprietary parallel synthesis technology, Mimotopes can synthesise hundreds of peptides simultaneously, thereby massively reducing the price and time to delivery.

High quality Peptide Libraries at affordable prices

30 Years Experience

Mimotopes is the founder of peptide library technology. We continued to grow and learn over the decades – now our expertise is unrivaled.

We work tirelessly to stay ahead of the game to ensure, as always, that we supply the best possible products.

Efficient & Economical Screening Solutions

Peptide Libraries have dozens of potential applications. From screening to epitope mapping, a peptide library can be exclusively designed to your specifications, for your research.

Discover crucial residues with an Alanine Scan Library
Map epitopes with an Overlapping Library
Narrow down the shortest active sequences with a Truncated Library

Dozens of Options to Customise

A standard Peptide Library can be supplied as with a precise length and offset designed to best suit your assays, but that’s not all. Modifications and labels can be applied to the termini or even within the sequence. Arrange a consultation to discuss your options and design your library.

Phone: +61 3 9565 1111
Fax: +61 3 9565 1199
Email: mimotopes@mimotopes.com

02/23/2024 21:36:07

Always On Authentication™

We are an enterprise authentication solution for increased security and productivity across pharmaceutical manufacturing.

Nymi Enterprise Edition™ delivers secure authentication solutions to pharmaceutical manufacturing environments. We replace existing point-in-time authentication models often used in manufacturing settings with one that sees its users in a continuously authenticated state throughout their workday.

Click the icons to the right for more information.

Visit nymi.com to learn more about our solution.

Security

Productivity

Compliance

Nymi™’s Enterprise Security Solution combines the security of biometrics with a convenient wearable device that addresses critical business needs for data integrity and productivity.

The Nymi Band™ is an innovative, wearable authentication device that allows an enterprise and its regulators’ full knowledge of who has access to facilities, equipment, and applications.
Multi-factor biometric authentication ensures each Nymi Band™ only works while on the wrist of an approved operator, and once
authenticated, cannot be transferred.

Employee Log Ins

Tap with Nymi Band™

Typing username
and password

repeat

100x

daily

Secure, non-repudiable, wireless taps of the Nymi Band™ make cumbersome repetitive tasks, like typing passwords and paper signatures a thing of the past.

With Nymi Enterprise Edition™, logins are replaced with a single action that takes merely a few seconds. The time saved by reducing login times and removing user authentication errors (failed usernames and passwords) leads to dramatic increases in efficiency for manufacturing environments.

Nymi™’s authentication technologies provide data integrity that assures compliance with standards such as the US Food and Drug Administration (FDA) CFR Part 11.

Nymi Enterprise Edition™ is able to assure the integrity of the data being produced on the floor through a combination of biometrics, on-body detection, and strong industry-standard cryptography.
It also provides real-time, on demand traceability and non-repudiable electronic records, which makes simpler, less intrusive audits a reality.

02/23/2024 21:36:07

Preview

January 2020

In the next issue of Pharma Technology Focus, we delve into the biggest topics set to influence the global market in 2020 and beyond. But first, we take a look back at the development of breast cancer treatment following the news that the number of cancer deaths has declined by almost 50% since the 1980s.

Looking forward, we investigate why access to PrEp drugs in England is restricted to patients in the NHS Impact trial despite the proven efficacy of the treatment, ask if Big Pharma can be taxed into putting patients before profits, and find out how companies are addressing the burden of endometriosis.

Plus, we track the rise of fake medications in Africa, examine a CAR-T therapy that protects non-diseased T cells, explore how 2019 Nobel Prize-winning research into how oxygen levels affect cellular metabolism and physiological function will change drug discovery, and finally, we look to the East to find out what is next for China’s surging market.

EDITORIAL

Editor | Eloise McLennan

Group Editor | Susanne Hauner

Commissioning Editor | Daniel Garrun

Writers | Allie Nawrat, Abi Millar, Chris Lo
Magazine Designer | Marzia Del Gaone

Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Petra Konyi-Kiss, Maria Gimenez, Martina Labaiova, Filipe Costa
Lead Designer | John Hammond
Digital Publishing Director | Duncan West

Advertising

Sales Manager | Nimai Amin

+44 (0) 207 936 6453

Marketing

For media partnership enquiries please contact our publishing assistant: Sophie Hoare

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Pharma Technology Focus is a product of Net Resources International. Copyright 2019 Net Resources International, a trading division of Kable Intelligence Limited. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.

02/23/2024 21:36:07